USFDA Flags One Observation at Cipla Plant

  Published 11 months ago

Cipla received one Form 483 observation after a USFDA cGMP inspection held from 26–30 May 2025.

  • Classification was officially communicated to Cipla via email on 4 August 2025 by the USFDA.
  • Cipla assured full cooperation and plans to address the observation comprehensively within the given timeline.
  • The company remains committed to compliance while focusing on growth in key global and emerging markets.

You might like these

Jash Expands with New Plant Deal

China Exports Rise, U.S. Trade Talks Continue Amid Tariff Hurdles

Trump & Musk: A Fracturing Alliance?

Aerolloy SMTC Castings Boost Defence

HCL Tech Shares Surge on AI Outlook

India Auctions Key Mineral Blocks

India Embraces Sustainable Standards

News that matters the most ⚡